Both the PI3K/Akt and MAPK pathways can phosphorylate MDM2 on serine residues 166 and 186 (Mayo and Donner, 2001; Feng et al., 2004; Hogan et al., 2008) to promote the oncogenic function of MDM2 in cancer cells. Here, MDM2 is linked to cancer.